Clinical Trial Update: The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating apremilast for female genital lichen planus; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Genital Disease
• Lichen Planus of Vulva

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Oslo University Hospital | Conditions: Lichen Planus of Vulva, Female Genital Disease | Phase 2 | Status: UNKNOWN